Medical product maker Convatec warns of higher cost from Iran War

British medical products maker Convatec on Thursday posted slower organic revenue growth for the first four months of 2026 and ​its CEO warned of higher costs in 2027 due to ‌the Iran conflict, sending shares 8% lower.